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Purpose of study
Data from randomized trials on the development of anae-
mia after interruption of therapy is not well described.
We aimed to describe the development of anaemia after
interruption of cART and the relationship between the
development of anaemia and clinical events (AIDS,
deaths or non-AIDS events) in the Strategic Management
of Antiretroviral Therapy (SMART) randomised trial.
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2248 patients from the SMART study were included.
We used Cox proportional hazards models to investigate
development of new (<12 mg/dl for females, <14 mg/dl
for males) or worsening (<8 mg/dl if anaemic at rando-
mization) anaemia and poisson regression analyses to
explore the relationship between anaemia and the devel-
opment of AIDS, death or non-AIDS events.
Results
The change in haemoglobin and anaemia after randomi-
sation to SMART is shown in Figure 1.
759 patients developed new or worsening anaemia;
420/1106 (38.0%) in the drug conservation (DC) arm
and 339/1127 (30.1%) in the virological suppression
(VS) arm; p<0.0001. In the first 4 months following ran-
domization, there was no difference in the risk of new
or worsening anaemia when comparing the DC arm to
the VS arm (adjusted relative hazard [RH] 1.02, 95% CI
0.82-1.25, p=0.88). After the initial 4 months, patients in
the DC arm had a significantly increased risk of new or
worsening anaemia (adjusted RH 1.56, 95% CI 1.28-1.89,
p<0.0001). 56 patients died during 5811 person-years of
follow-up (PYFU), 56 developed AIDS (5728 PYFU) and
100 developed a non-AIDS event (5664 PYFU). Cur-
rently anaemic patients had an increased incidence of
AIDS (adjusted IRR 2.31; 95% CI 1.34-3.98), death (2.19;
95% CI 1.23-3.87) and non-AIDS events (2.98; 95% CI
2.014.40) compared to non-anaemic patients.
Conclusions
Patients in SMART who interrupted cART had a higher
risk of new or worsening anaemia. Patients with anaemia
had a higher incidence of AIDS, non-AIDS defining events
or deaths; whether this relationship is causal or a conse-
quence of the disease is not clear but suggests that anae-
mia, or drop in haemoglobin, might be of use as a pre-
clinical marker of disease. Further research is warranted to
further understand the occurrence of anaemia, its conse-
quences and underlying pathological mechanisms.
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